IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the hematologic effects of IMG-7289 therapy in ET and
PV patients who require platelet, White Blood Cell (WBC) or Red Blood Cell (RBC) control, and
have failed at least one standard therapy.